Simsek Papur Ozlenen, Sun Aomin, Glatz Jan F C, Luiken Joost J F P, Nabben Miranda
Department of Genetics & Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.
Department of Molecular Medicine, Institute of Health Science, Dokuz Eylul University, Izmir, Turkey.
Front Cardiovasc Med. 2018 Jun 7;5:65. doi: 10.3389/fcvm.2018.00065. eCollection 2018.
Protein kinase-D (PKD) is increasingly recognized as a key regulatory signaling hub in cardiac glucose uptake and also a major player in the development of hypertrophy. Glucose is one of the predominant energy substrates for the heart to support contraction. However, a cardiac substrate switch toward glucose over-usage is associated with the development of cardiac hypertrophy. Hence, regulation of PKD activity must be strictly coordinated. This review provides mechanistic insights into the acute and chronic regulatory functions of PKD signaling in the healthy and hypertrophied heart. First an overview of the activation pathways of PKD1, the most abundant isoform in the heart, is provided. Then the various regulatory roles of the PKD isoforms in the heart in relation to cardiac glucose and fatty acid metabolism, contraction, morphology, function, and the development of cardiac hypertrophy are described. Finally, these findings are integrated and the possibility of targeting this kinase as a novel strategy to combat cardiac diseases is discussed.
蛋白激酶-D(PKD)日益被认为是心脏葡萄糖摄取中的关键调节信号枢纽,也是肥大发展的主要参与者。葡萄糖是心脏支持收缩的主要能量底物之一。然而,心脏底物向过度使用葡萄糖的转变与心脏肥大的发展有关。因此,PKD活性的调节必须严格协调。本综述提供了关于PKD信号在健康和肥大心脏中的急性和慢性调节功能的机制见解。首先概述了心脏中最丰富的异构体PKD1的激活途径。然后描述了PKD异构体在心脏中与心脏葡萄糖和脂肪酸代谢、收缩、形态、功能以及心脏肥大发展相关的各种调节作用。最后,整合这些发现并讨论将这种激酶作为对抗心脏病的新策略的可能性。